Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany; Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Curr Opin Immunol. 2022 Jun;76:102180. doi: 10.1016/j.coi.2022.102180. Epub 2022 Apr 21.
The central nervous system (CNS) is, more than other organs, particularly vulnerable to inflammation and immune responses must be tightly controlled in order to maintain host protection. Accordingly, neuroinflammation is an orchestrated process involving various cell types that may dramatically change their phenotypic and functional properties upon entering the CNS. Recent advances in single-cell multiomics offer the unique opportunity to resolve this cellular heterogeneity in a holistic fashion and reshape our understanding of the molecular and cellular processes during neuroinflammation. Here, we provide an overview of technical advances in single-cell multiomics and the tremendous impact on our basic understanding of neuroinflammation. We discuss insights obtained in neuroinflammatory diseases and elaborate to which extent these tool sets could be applied in a clinical setting.
中枢神经系统 (CNS) 比其他器官更容易受到炎症和免疫反应的影响,因此必须严格控制免疫反应,以维持宿主的保护。因此,神经炎症是一个协调的过程,涉及各种细胞类型,这些细胞在进入中枢神经系统时可能会显著改变其表型和功能特性。单细胞多组学的最新进展为全面解析这种细胞异质性提供了独特的机会,并重塑了我们对神经炎症过程中分子和细胞过程的理解。在这里,我们提供了单细胞多组学技术进展的概述及其对我们对神经炎症基本认识的巨大影响。我们讨论了在神经炎症性疾病中获得的见解,并详细说明了这些工具集在临床环境中的应用程度。